default author photo

Sunil Kumar Mishra

Medanta-The Medicity - Division of Endocrinology and Diabetes

SCHOLARLY PAPERS

1

DOWNLOADS

112

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Efficacy and Safety of Degludec U100 Versus Glargine U300 for the Hospital Management of Patients with Type 2 Diabetes: A Prospective, Open-Label, Non-Inferiority Randomized Trial

Number of pages: 37 Posted: 15 Jun 2022
Medanta-The Medicity - Division of Endocrinology and Diabetes, Medanta-The Medicity - Division of Endocrinology and Diabetes, Medanta-The Medicity - Division of Endocrinology and Diabetes, Medanta-The Medicity - Department of Clinical Research and Studies, Medanta-The Medicity - Division of Endocrinology and Diabetes, Medanta-The Medicity - Division of Endocrinology and Diabetes, Medanta-The Medicity - Division of Endocrinology and Diabetes, Medanta-The Medicity - Division of Endocrinology and Diabetes, Medanta-The Medicity - Division of Endocrinology and Diabetes, Medanta-The Medicity - Division of Endocrinology and Diabetes, Medanta-The Medicity - Division of Endocrinology and Diabetes, Medanta-The Medicity - Department of Clinical Research and Studies and Medanta-The Medicity - Division of Endocrinology and Diabetes
Downloads 112 (630,858)

Abstract:

Loading...

Degludec U100, glargine U300, hospital care, inpatient management, hypoglycemia, CGMS